Health Care [ 5/12 ] | Biotechnology [ 51/74 ]
NASDAQ | Common Stock
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases.
It develops a pipeline of product candidates targeting inflammatory and infectious diseases.
The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation.
The company was incorporated in 2005 and is headquartered in Austin, Texas.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 31, 26 | -0.18 Increased by +49.41% | - |
| Feb 25, 26 | -0.88 Decreased by -155.90% | - |
| Nov 28, 25 | -0.20 Decreased by -21.51% | - |
| Aug 29, 25 | -0.06 Increased by +85.95% | - |
| May 8, 25 | -0.36 Decreased by -8.68% | - |
| Mar 13, 25 | -0.34 Decreased by -126.33% | - |
| Nov 7, 24 | -0.16 Increased by +31.96% | - |
| Aug 12, 24 | -0.43 Decreased by -48.68% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 0.00 Decreased by -100.00% | -5.50 M Increased by +49.42% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 25 | 0.00 Decreased by N/A% | -26.89 M Decreased by -155.92% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -6.01 M Decreased by -19.80% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -1.76 M Increased by +86.50% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 867.00 K Decreased by -66.91% | -10.88 M Decreased by -8.82% | Decreased by -1.26 K% Decreased by -228.84% |
| Dec 31, 24 | 0.00 Decreased by -100.00% | -10.51 M Decreased by -126.71% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -5.01 M Increased by +31.90% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -13.01 M Decreased by -48.78% | Decreased by N/A% Decreased by N/A% |